Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent Chemotherapy-Induced Thrombocytopenia By Ogkologos - March 26, 2026 323 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the RECITE study Source RELATED ARTICLESMORE FROM AUTHOR Non-pharmacological interventions – are they important to patients with cancer? Two novel bispecific antibodies in combination with chemotherapy show efficacy in neuroendocrine carcinomas Sacituzumab tirumotecan plus pembrolizumab significantly prolongs progression-free survival in advanced non-small cell lung cancer MOST POPULAR An existing blood test for ovarian cancer has been re-evaluated. The... October 28, 2020 Holidays and Hope When a Loved One Has Advanced Cancer December 20, 2023 Longest Follow-Up of CAR T-Cell Therapy in Mantle Cell Lymphoma Points... June 14, 2022 Catch-Up HPV Testing May Help Prevent Cervical Cancer in Some Over... September 1, 2023 Load more HOT NEWS FDA Approves Tebentafusp-tebn for Unresectable or Metastatic Uveal Melanoma For Children with Neuroblastoma, Trial Results Highlight Continued Evolution of Treatment NICE doesn’t recommend olaparib for patients with certain prostate cancers Reunión anual de la American Society of Clinical Oncology de 2021:...
